Neil Freiman

Elon Musk has called aging a very solvable problem and said that age reversal is coming.

Sam Altman, who's the CEO of OpenAI, has backed a number of startups or one startup in the space.

Jeff Bezos has backed another.

Brian Armstrong, who's the Coinbase CEO, actually co-founded another longevity startup called New Limit.

So there's a lot of attention and money being thrown at longevity by these billionaires because it is expensive.

But they're saying that this is potentially a new frontier of science with a lot of serious names attached as well.

Right.

Maybe get them to the teen stage without the rebellion.

But yeah, there's a couple other names to know.

Yamanaka factor, as you mentioned, this was named after this guy in Japan, a scientist and a surgeon, Shinya Yamanaka, who in 2007 was the first person to first successfully reprogram adult human cells.

And he won that Nobel Prize for it.

Then the other person to know is David Sinclair.

He is the co-founder of Life Biosciences, the company that's doing this particular study.

He is probably the most controversial but most accomplished scientist in this particular field.

He has talked about—he runs a lab in Harvard, which has spawned a lot of these companies.

He has talked about bodies being like computers that can be programmed and reprogrammed and rebooted.

So he's been a huge booster of this.

At the same time of him being a huge booster, he's also—

made some pretty, maybe not outlandish claims, but very ambitious claims about longevity science where others in his field have sort of pushed back and said, look, he said stuff like, yeah, the person who's going to live to 150 years old has already been born.

And some of the people who have worked with him in the past have called him a snake oil salesman and talked up his accomplishments a little too much.